Congenital Heart Disease Ups Endotoxemia Risk in Children

Higher levels of intestinal fatty acid binding protein, endotoxin with congenital heart disease

WEDNESDAY, Sept. 14 (HealthDay News) -- Children undergoing surgery for congenital heart disease are at an increased risk of intestinal mucosal injury, endotoxemia, and activation of endotoxin signaling pathways that are associated with adverse outcome, according to a study published online Aug. 25 in the American Journal of Respiratory and Critical Care Medicine.

Nazima Pathan, Ph.D., M.R.C.P.C.H., from the Royal Brompton Hospital in London, and colleagues investigated the role of intestinal injury and endotoxemia in the pathogenesis of organ dysfunction following surgery for children with congenital heart disease (median age, 11.17 months). A total of 61 children undergoing surgery for congenital heart disease were assessed for blood levels of intestinal fatty acid binding protein (IFABP) and endotoxin, and underwent global transcriptomic profiling and assays of monocyte endotoxin receptor expression.

The investigators found greater levels of IFABP and endotoxin in children with duct-dependent cardiac lesions. The severity of vital organ dysfunction and intensive care stay was correlated with endotoxemia. Activation of pathogen sensing, antigen processing, and immune suppressing pathways was found at the genomic level postoperatively, as was downregulation of pathogen sensing receptors on circulating immune cells.

"Children undergoing surgery for congenital heart disease are at increased risk of intestinal mucosal injury and endotoxemia," the authors write.

Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95

Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95

Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events